Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlbAlsace: Albumin Strategies in SIRS
NCT02755155Phase 4Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Sep 2016
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in hypoalbuminemia, Systemic Inflammatory Response Syndrome (SIRS), sponsored by Strasbourg University Hospital. Started Sep 2016; status: terminated.
02
Drugs
albumin (human)
03
Conditions
hypoalbuminemiaSystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT02755155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755155.